CAMBRIDGE, Mass., July 12, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Tuesday, July 30, 2013, to provide a business update and to discuss its second-quarter financial and operational results.
To listen to the live webcast of the call, please visit the "Investors" section of the Company's website at www.aegerion.com . Individuals may also participate in the call via telephone by dialing (866) 516-3002 or (760) 298-5082. Interested parties unable to join the live call may access an archived version of the webcast on Aegerion's website for up to 30 days following the call.
CONTACT: Aegerion Pharmaceuticals, Inc. Amanda Murphy, Manager, IR 857-242-5024
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts